NEJM Perspective Analyzes Direct-To-Consumer Advertising for Prescription Drugs, Medical Devices
"DTCA for PTCA -- Crossing the Line in Consumer Health Education?" New England Journal of Medicine: In the NEJM perspective, William Boden of the University of Buffalo Schools of Medicine and Public Health and Health Professions and George Diamond of Cedars-Sinai Medical Center discuss how direct-to-consumer advertising for prescription drugs and medical devices can fail to fully disclose the benefits and risks of the medications. Boden and Diamond also examine whether DTC ads are targeting millions of people who are "ill-equipped" to make decisions about complex therapeutic issues (Boden/Diamond, NEJM, 5/22).
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
